0% for two years, 100% for one, 200 after: US' latest tariff move over generic medicines
In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion
- Center-left1
- Center2
2 agency rewrites / co-publications detected
Summary
In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion. In the US, Indian generic medicines make up nearly 40 per cent by volume. India and the US struck a trade pact in February, which stipulates that India would "receive negotiated outcomes with respect to generic pharmaceuticals and ingredients." But his previous threats to tariff pharma suppliers had put cheap supplies from India at risk.
Cross-referenced from 3 sources.
Factual coreconfirmed by several independent voices
In 2025, India exported USD 9.7 billion worth of pharmaceuticals to the US, accounting for 38 per cent of its total global pharma exports of USD 25.8 billion
reliability low1/3 sources
Reported detailssecondary facts, each attributed to its source
In the US, Indian generic medicines make up nearly 40 per cent by volume.
according to NDTV - Top StoriesIndia and the US struck a trade pact in February, which stipulates that India would "receive negotiated outcomes with respect to generic pharmaceuticals and ingredients." But his previous threats to tariff pharma suppliers had put cheap supplies from India at risk.
according to NDTV - Top Stories
Disputedincompatible versions — to verify
No factual contradiction detected between sources.
Framing by sidesame fact, different words — loaded terms highlighted
No notable framing divergence.
Blind spotwhat one side keeps silent
No blind spot detected: every side covers the same facts.
Sources2 sources cross-checked
Center-left1
Center1
